Table 2.
Disease characteristics of the study population
| Characteristic | n (%) |
|---|---|
| Subclass of the disease (n = 115) | |
| SJS | 54 (47.0) |
| SJS/TEN overlap | 22 (19.1) |
| TEN | 39 (33.9) |
| SCORTEN | |
| 1 | 5 (20.8) |
| 2 | 11 (45.8) |
| 3 | 5 (20.8) |
| 4 | 2 (8.3) |
| 6 | 1 (4.2) |
| Method of diagnosis (n = 115) | |
| Histopathological | 2 (1.7) |
| Clinical | 113 (98.3) |
| Origin of the skin reaction (n = 115) | |
| Home | 105 (91.3) |
| Hospital | 10 (8.7) |
| Family history (n = 115) | |
| Positive | 2 (1.7) |
| Negative | 113 (98.3) |
| Median latency time from exposure to drug to onset of symptoms | 4 days (range 2–14) |
SJS Stevens–Johnson syndrome, TEN toxic epidermal necrolysis